Intriguingly, another Jak2 negative regulator, SOCS2 has been found to be epigenetically downregulated in two out of seven MPN patients, suggesting lack of negative regulator might be an important second step in the genesis of cytokine-independent MPN clones [48]. Here, JAK2 is linked to myeloproliferative disorder.